Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2550 of 3173 entries
View as:

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Phase: N/A Priority: Normal
NCT ID: NCT00141245 Org: User:
Start: 10/31/98 End: 11/30/05 Due: 11/30/06

Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)

Phase: N/A Priority: Normal
NCT ID: NCT00141193 Org: User:
Start: 02/28/01 End: 05/31/07 Due: 05/31/08

An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation

Phase: N/A Priority: Normal
NCT ID: NCT00731562 Org: User:
Start: 07/31/08 End: 09/30/08 Due: 09/30/09

Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT05572567 Org: User:
Start: 10/10/22 End: 10/10/22 Due: 10/10/23

Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy

Phase: N/A Priority: Normal
NCT ID: NCT04281485 Org: User:
Start: 11/05/20 End: 04/15/39 Due: 04/15/40

A SINGLE-DOSE, 2-ARM, PHARMACOKINETIC STUDY OF PF-06439535 (CN) AND EUROPEAN UNION SOURCED BEVACIZUMAB IN CHINESE HEALTHY MALE VOLUNTEERS

Phase: N/A Priority: Normal
NCT ID: NCT04126044 Org: User:
Start: 01/22/21 End: 07/10/21 Due: 07/10/22

Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT01162889 Org: User:
Start: 06/30/10 End: 01/31/12 Due: 01/31/13

Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia

Phase: N/A Priority: Normal
NCT ID: NCT00944294 Org: User:
Start: 02/29/04 End: 04/30/06 Due: 04/30/07

A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT01260805 Org: User:
Start: 09/30/10 End: 10/31/10 Due: 10/31/11

Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin

Phase: N/A Priority: Normal
NCT ID: NCT01592240 Org: User:
Start: 07/31/12 End: 05/31/13 Due: 05/31/14

Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in Finland

Phase: N/A Priority: Normal
NCT ID: NCT01787565 Org: User:
Start: 01/31/13 End: 01/31/14 Due: 01/31/15

Study Evaluating Ibuprofen 600 mg Extended Release (ER) For Dental Pain

Phase: N/A Priority: Normal
NCT ID: NCT00913627 Org: User:
Start: 05/07/09 End: 08/05/09 Due: 08/05/10

A Study Comparing Subcutaneous Injection of Sayana Press In the Upper Arm Versus Anterior Thigh and Abdomen

Phase: N/A Priority: Normal
NCT ID: NCT04893798 Org: User:
Start: 09/16/21 End: 07/23/25 Due: 07/23/26

Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03499353 Org: User:
Start: 08/27/18 End: 09/23/20 Due: 09/23/21

NOAC Portuguese Real World Study

Phase: N/A Priority: Normal
NCT ID: NCT04808934 Org: User:
Start: 06/01/20 End: 12/01/20 Due: 12/01/21

Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 Years

Phase: N/A Priority: Normal
NCT ID: NCT01706367 Org: User:
Start: 09/30/12 End: 01/31/14 Due: 01/31/15

Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal
NCT ID: NCT00716625 Org: User:
Start: 06/30/08 End: 10/31/15 Due: 10/31/16

An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01175135 Org: User:
Start: 10/31/10 End: 08/31/11 Due: 08/31/12

A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.

Phase: N/A Priority: Normal
NCT ID: NCT05994963 Org: User:
Start: 09/01/23 End: 02/26/24 Due: 02/26/25

A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin

Phase: N/A Priority: Normal
NCT ID: NCT02554877 Org: User:
Start: 10/31/15 End: 08/31/16 Due: 08/31/17

A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections

Phase: N/A Priority: Normal
NCT ID: NCT00360607 Org: User:
Start: 07/31/04 End: 04/30/05 Due: 04/30/06

Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA

Phase: N/A Priority: Normal
NCT ID: NCT00858780 Org: User:
Start: 01/31/09 End: 06/30/12 Due: 06/30/13

An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00247676 Org: User:
Start: 02/28/06 End: 02/28/09 Due: 02/28/10

Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03317496 Org: User:
Start: 12/21/17 End: 12/20/22 Due: 12/20/23

Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)

Phase: N/A Priority: Normal
NCT ID: NCT04018001 Org: User:
Start: 04/12/19 End: 04/25/19 Due: 04/25/20